BCYC
HEALTHCAREBicycle Therapeutics Plc
$5.15+0.25 (+5.10%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BCYC Today?
No stock-specific AI insight has been generated for BCYC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.24$9.36
$5.15
Fundamentals
Market Cap$341M
P/E Ratio—
EPS$-3.15
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin—
Debt / Equity—
Trading
Volume780K
Avg Volume (10D)—
Shares Outstanding50.4M
BCYC News
21 articles- European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday TradingYahoo Finance·May 7, 2026
- European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for WeekYahoo Finance·May 1, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingYahoo Finance·Apr 30, 2026
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial ResultsYahoo Finance·Apr 30, 2026
- Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual MeetingYahoo Finance·Apr 21, 2026
- Peptide Drug Conjugate Market Landscape Report 2026: A $1.5 Billion Opportunity by 2031 - Drug Sales, Patent, Price, Dosage, Proprietary Technologies & OutlookGlobeNewswire Inc.·Apr 21, 2026
- Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026Yahoo Finance·Apr 20, 2026
- Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline RefocusYahoo Finance·Apr 17, 2026
- European Equities Traded in the US as American Depositary Receipts Declining in Thursday TradingYahoo Finance·Apr 16, 2026
- Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to TradeYahoo Finance·Apr 16, 2026
- European Equities Traded in the US as ADRs Rise in Tuesday TradingYahoo Finance·Apr 14, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·Apr 13, 2026
- RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11Yahoo Finance·Apr 4, 2026
- European Equities Traded in the US as American Depositary Receipts Rising Sharply in Wednesday TradingYahoo Finance·Apr 1, 2026
- European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday TradingYahoo Finance·Mar 25, 2026
- After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)Yahoo Finance·Mar 24, 2026
- European Equities Traded in the US as American Depositary Receipts Climb in Monday TradingYahoo Finance·Mar 23, 2026
- Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerYahoo Finance·Mar 23, 2026
- European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Drop Over 2% for WeekYahoo Finance·Mar 20, 2026
- European Equities Traded in US as ADRs Fall in Wednesday TradingYahoo Finance·Mar 18, 2026
- Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026Yahoo Finance·Mar 18, 2026
All 21 articles loaded
Price Data
Open$4.97
Previous Close$4.90
Day High$5.22
Day Low$4.85
52 Week High$9.36
52 Week Low$4.24
52-Week Range
$4.24$9.36
$5.15
Fundamentals
Market Cap$341M
P/E Ratio—
EPS$-3.15
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin—
Debt / Equity—
Trading
Volume780K
Avg Volume (10D)—
Shares Outstanding50.4M
About Bicycle Therapeutics Plc
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—